Simultaneous determination of free and total prostate-specific antigen by a magnetic particle-based time-resolved fluoroimmunoassay

被引:9
|
作者
Zhou, Bin [1 ]
Zhang, Jue [1 ]
Lv, Zhongwei [2 ]
Fan, Jun [1 ]
Zhang, Yi [1 ]
Huang, Biao [1 ]
机构
[1] Jiangsu Inst Nucl Med, Jiangsu Key Lab Mol Nucl Med, Minist Hlth, Dept Biotechnol,Key Lab Nucl Med, Wuxi, Jiangsu, Peoples R China
[2] Tongji Univ, Sch Med, Dept Nucl Med, Shanghai Peoples Hosp 10, Shanghai, Peoples R China
关键词
free and total prostate-specific antigen; magnetic nanoparticles; simultaneous detection; time-resolved fluoroimmunoassay; IMMUNOASSAY; CANCER; MEN;
D O I
10.1002/jcla.22137
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
ObjectivesIn this paper, a novel, sensitive and rapid method to simultaneously determine the free and total prostate-specific antigen (fPSA and tPSA) in serum by combining a time-resolved fluoroimmunoassay (TRFIA) and immunomagnetic separation was described. MethodsThe new approach uses magnetic particles as an immobilization matrix and means of separation, whereas the luminescent europium (Eu) and samarium (Sm) chelates are used as probes. The proposed method was evaluated via a single-step, sandwich-type TRFIA immunoassay of tPSA and fPSA as model analytes in serum. ResultsA new one-step method to simultaneously detect fPSA and tPSA in less than 15minutes was built up with the detection limits 0.006ng/mL for fPSA and 0.05ng/mL for tPSA. The assay ranges for fPSA and tPSA were both 0.5-100ng/mL, whereas the average recovery of those two obtained by our original mode were 95.9% and 95.3%, respectively. The present new TRFIA method carrying larger reproducibility, higher recovery, and sensitive specificity was demonstrated to be widely acceptable. ConclusionsThis simultaneous determination method containing a fast and sensitive approach can be put into an important position to screening large quantities of specimen, and be commonly applied to the clinical determination of fPSA and tPSA in human serum.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
    Avci, Sinan
    Onen, Efe
    Caglayan, Volkan
    Kilic, Metin
    Sambel, Murat
    Oner, Sedat
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 1 - 6
  • [32] Prediction of prostate volume based on total and free serum prostate-specific antigen:: Is it reliable?
    Morote, J
    Encabo, G
    López, M
    de Torres, IM
    EUROPEAN UROLOGY, 2000, 38 (01) : 91 - 95
  • [33] Different free prostate-specific antigen to total prostate-specific antigen ratios using three detecting systems
    Huang, Hui-Qing
    Zhang, Yan
    Xu, Hua-Guo
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (02)
  • [34] DESIGN OF A TIME-RESOLVED FLUOROMETRIC HYBRIDIZATION ASSAY FOR THE MESSENGER-RNA OF PROSTATE-SPECIFIC ANTIGEN
    GALVAN, B
    CHRISTOPOULOS, TK
    DIAMANDIS, EP
    CLINICAL CHEMISTRY, 1995, 41 (11) : 42 - 42
  • [35] Simultaneous quantitation of carbohydrate antigen 125 and carcinoembryonic antigen in human serum via time-resolved fluoroimmunoassay
    Huang, Zhen
    Zhai, Xiang-Ming
    Wang, Hao
    Deng, Qiao-Ting
    Li, Kun
    Liu, Bi-Sen
    Wang, Gang
    Liu, Tian-Cai
    CLINICA CHIMICA ACTA, 2018, 483 : 222 - 226
  • [36] The impact of intraoperative manipulation of the prostate on total and free prostate-specific antigen
    Oberpenning, F
    Schmid, HP
    Fuchs-Surdel, W
    Hertle, L
    Semjonow, A
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 154 - 160
  • [37] Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen
    Morgan, TO
    McLeod, DG
    Leifer, ES
    Murphy, GP
    Moul, JW
    UROLOGY, 1996, 48 (6A) : 76 - 80
  • [38] Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology
    Roehrborn, CG
    Gregory, A
    Mcconnell, JD
    Sagalowsky, AI
    Wians, FH
    UROLOGY, 1996, 48 (6A) : 23 - 32
  • [39] Determination of ochratoxin A by polyclonal antibodies based sensitive time-resolved fluoroimmunoassay
    Biao Huang
    Wenyi Tao
    Jin Shi
    Luhong Tang
    Jian Jin
    Archives of Toxicology, 2006, 80 : 481 - 485
  • [40] Determination of ochratoxin A by polyclonal antibodies based sensitive time-resolved fluoroimmunoassay
    Huang, Biao
    Tao, Wenyi
    Shi, Jin
    Tang, Luhong
    Jin, Jian
    ARCHIVES OF TOXICOLOGY, 2006, 80 (08) : 481 - 485